TipRanks
Go Ultimate55% OFF

Jean Duvall Insider Profile

4 Followers

Jean Duvall, Director at Ondine Biomedical, Inc., holds 1.61M shares in Ondine Biomedical, Inc. (Ticker: GB:OBI). Most recently, Jean Duvall Bought 170,815 shares of Ondine Biomedical, Inc. on Oct 20, 2026 for an estimated value of 17.08K .

Jean Duvall's Trading History

OBI
Ondine Biomedical, Inc.
Oct 20, 2026DirectorInformative Buy17.08K£156.87K
GB:OBI
Insider Shares: 1.61M (28.67%)
DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 20, 2026Informative Buy£17.08K170,815£10.00-4.80%―
Apr 29, 2026Uninformative Buy£18.97K158,042£12.00――
Aug 28, 2025Uninformative Buy£17.47K116,487£15.00――
Nov 01, 2024Informative Buy£35.78K420,923£8.00+51.40%―
May 04, 2024Informative Buy£37.50K535,683£7.00+36.30%―

You May Also Like

Jean Duvall insider profile FAQ

What is the percentage of profitable transactions made by Jean Duvall?
The percentage of profitable transactions made by Jean Duvall is 50%.
What is the average return per transaction made by Jean Duvall?
The average return per transaction made by Jean Duvall is 17.60%.
What stocks does Jean Duvall hold?
Jean Duvall holds: GB:OBI stocks.
What was Jean Duvall’s latest transaction?
Jean Duvall’s latest transaction was an Informative Buy of 17.08K .
What was Jean Duvall's most profitable transaction?
Jean Duvall’s most profitable transaction was an Informative Buy of GB:OBI stock on November 1, 2024. The return on the trade was 51.40%.
What is Jean Duvall's role in Ondine Biomedical, Inc.?
Jean Duvall's role in Ondine Biomedical, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.